Anaphylaxis

Publication Date: December 17, 2023

Key Points

Key Points

  • Anaphylaxis is an acute, potential life-threatening systemic allergic reaction that may have a wide range of clinical manifestations.
  • Severe anaphylaxis and/or the need for repeated doses of epinephrine to treat anaphylaxis are risk factors for biphasic anaphylaxis.
  • Antihistamines and/or glucocorticoids are not reliable interventions to prevent biphasic anaphylaxis.

Diagnosis

...iagnosi...

...ask Force suggests that a clinician incorporat...


...nt Task Force suggests extended clinical observat...


Treatment

...reatment...

...oint Task Force suggests against administering glu...

The Joint Task Force suggests in fav...

...Task Force suggests against routinely adminis...

...oint Task Force suggests in favor adminis...


...Practice Statemen...

...phrine as the first-line pharmacoth...

...o not delay the administration of epine...

...r diagnosis and treatment of anaphyla...

...th anaphylaxis should receive education o...


...uggested Key Clinica...

...Severe anaphylaxis and/or the need for...


Illustration